Compound Detail
CHEMBL1614701
SELUMETINIB 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL1614701 |
| Name | SELUMETINIB |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | CYOHGALHFOKKQC-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
430
Targets
593
Activities
3
Assay Types
6
PK Parameters
20
Publications
5
Known Names
20
Indications
2
Mechanisms
Molecular Properties
457.7
MW (Da)
3.53
ALogP
6
HBA
3
HBD
88.4
PSA (Ų)
0.39
QED
0
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2020 |
| Availability | Prescription |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Dual specificity mitogen-activated protein kinase kinase 1 inhibitor | INHIBITOR | Dual specificity mitogen-activated protein kinase kinase 1 | ✓ | ✓ |
| Dual specificity mitogen-activated protein kinase kinase 2 inhibitor | INHIBITOR | Dual specificity mitogen-activated protein kinase kinase 2 | ✓ | ✓ |
Indications
Neoplasms Neoplasms Carcinoma, Non-Small-Cell Lung Thyroid Neoplasms Thyroid Neoplasms Thyroid Neoplasms Uveal Melanoma Uveal Melanoma Adenocarcinoma Adenocarcinoma, Follicular Bile Duct Neoplasms Biliary Tract Neoplasms Breast Neoplasms Breast Neoplasms Carcinoma, Squamous Cell Carcinoma, Squamous Cell Cholangiocarcinoma Colorectal Neoplasms Colorectal Neoplasms Gallbladder Neoplasms
ATC Classification
L01EE04
selumetinib
Level 1: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Level 2: ANTINEOPLASTIC AGENTS
Activity Summary
IC50 565 meas. best 8.5
Kd 26 meas. best 7.85
EC50 2 meas. best 6.12
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| CHP-212 CHEMBL1075423 | IC50 | 8.5 | 8.5 | 3.2 | 1 |
| Dual specificity mitogen-activated protein kinase kinase 1 CHEMBL3587 | IC50 | 8.05 | 6.3062 | 9.0 | 13 |
| Dual specificity mitogen-activated protein kinase kinase; MEK1/2 CHEMBL2111289 | IC50 | 7.85 | 7.85 | 14.0 | 2 |
| Unchecked CHEMBL612545 | IC50 | 7.85 | 7.85 | 14.0 | 1 |
| Unchecked CHEMBL612545 | Kd | 7.85 | 7.85 | 14.0 | 1 |
| SW-620 CHEMBL612262 | IC50 | 7.82 | 7.17 | 15.0 | 2 |
| H9 CHEMBL614806 | IC50 | 7.64 | 7.64 | 22.9 | 1 |
| HL-60 CHEMBL383 | IC50 | 7.61 | 7.61 | 24.6 | 1 |
| A-375 CHEMBL613859 | IC50 | 7.51 | 7.51 | 31.0 | 1 |
| NOMO-1 CHEMBL2366198 | IC50 | 7.5 | 7.5 | 32.0 | 1 |
| HepG2 CHEMBL395 | IC50 | 7.5 | 7.5 | 32.0 | 1 |
| DU-4475 CHEMBL2366246 | IC50 | 7.47 | 7.47 | 33.7 | 1 |
| M14 CHEMBL614317 | IC50 | 7.43 | 7.43 | 36.9 | 1 |
| Dual specificity mitogen-activated protein kinase kinase 1 CHEMBL3587 | Kd | 7.39 | 7.0975 | 41.0 | 4 |
| Dual specificity mitogen-activated protein kinase kinase 2 CHEMBL2964 | Kd | 7.28 | 6.53 | 52.0 | 4 |
| Malme-3M CHEMBL614021 | IC50 | 7.23 | 7.23 | 59.0 | 1 |
| COLO 205 CHEMBL614561 | IC50 | 7.23 | 7.23 | 59.0 | 1 |
| ASPC1 CHEMBL612588 | IC50 | 7.19 | 6.84 | 64.2 | 2 |
| NON-PROTEIN TARGET CHEMBL3879801 | IC50 | 7.16 | 6.3533 | 69.0 | 3 |
| HT-144 CHEMBL2366291 | IC50 | 7.05 | 7.05 | 89.0 | 1 |
| SK-N-AS CHEMBL1075578 | IC50 | 7.03 | 7.03 | 92.8 | 1 |
| LB2518-MEL CHEMBL2366335 | IC50 | 7.03 | 7.03 | 93.8 | 1 |
| C32 CHEMBL1075401 | IC50 | 7.01 | 7.01 | 98.2 | 1 |
| BaF3 CHEMBL614524 | IC50 | 7.0 | 7.0 | 100.0 | 1 |
| BHT-101 CHEMBL1075398 | IC50 | 6.97 | 6.97 | 106.9 | 1 |
| KY821 CHEMBL2366190 | IC50 | 6.97 | 6.97 | 107.2 | 1 |
| SK-CO-1 CHEMBL1075576 | IC50 | 6.93 | 6.93 | 117.0 | 1 |
| CP50-MEL-B CHEMBL2366076 | IC50 | 6.89 | 6.89 | 127.9 | 1 |
| MEL-HO CHEMBL1075500 | IC50 | 6.86 | 6.86 | 138.8 | 1 |
| MIA PaCa-2 CHEMBL614725 | IC50 | 6.85 | 6.45 | 142.0 | 2 |
| EOL1 CHEMBL614489 | IC50 | 6.84 | 6.84 | 144.8 | 1 |
| DOK CHEMBL1075435 | IC50 | 6.83 | 6.83 | 147.1 | 1 |
| SH-4 CHEMBL2366309 | IC50 | 6.78 | 6.78 | 166.5 | 1 |
| BPH-1 CHEMBL2366131 | IC50 | 6.74 | 6.74 | 182.3 | 1 |
| HuP-T4 CHEMBL1075478 | IC50 | 6.71 | 6.71 | 195.3 | 1 |
| Structural maintenance of chromosomes protein 2 CHEMBL4105890 | Kd | 6.68 | 6.68 | 209.0 | 1 |
| HTC-C3 CHEMBL1075472 | IC50 | 6.67 | 6.67 | 214.6 | 1 |
| A549 CHEMBL392 | IC50 | 6.67 | 6.0633 | 214.1 | 3 |
| KU812 cell line CHEMBL613997 | IC50 | 6.67 | 6.67 | 211.7 | 1 |
| A101D CHEMBL2366306 | IC50 | 6.62 | 6.62 | 240.3 | 1 |
| ONS-76 CHEMBL2366068 | IC50 | 6.61 | 6.61 | 244.5 | 1 |
| RKO CHEMBL614879 | IC50 | 6.61 | 6.61 | 248.4 | 1 |
| WM-115 CHEMBL1075611 | IC50 | 6.57 | 6.57 | 267.5 | 1 |
| HCC 2998 CHEMBL613855 | IC50 | 6.57 | 6.57 | 269.1 | 1 |
| C2BBe1 CHEMBL2366283 | IC50 | 6.56 | 6.56 | 272.6 | 1 |
| RVH-421 CHEMBL1075567 | IC50 | 6.55 | 6.55 | 279.4 | 1 |
| H-EMC-SS CHEMBL1075451 | IC50 | 6.54 | 6.54 | 291.0 | 1 |
| ML-2 CHEMBL614356 | IC50 | 6.53 | 6.53 | 293.6 | 1 |
| UACC-257 CHEMBL612796 | IC50 | 6.49 | 6.49 | 321.8 | 1 |
| CAL-39 CHEMBL1075410 | IC50 | 6.48 | 6.48 | 332.3 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 1.0 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 1.0 | mL.min-1.kg-1 | Rattus norvegicus |
| F | 14.0 | % | Rattus norvegicus |
| F | 24.0 | % | Rattus norvegicus |
| T1/2 | 3.8 | hr | Rattus norvegicus |
| T1/2 | 4.1 | hr | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 27448918 | 10.1016/j.ejmech.2016.06.043 | SW480 | 19 |
| 22037378 | 10.1038/nbt.1990 | Tyrosine-protein kinase ABL1 | 15 |
| - | 10.6019/CHEMBL5674860 | Colon cancer organoid | 12 |
| - | 10.6019/CHEMBL5724558 | Colon cancer organoid | 12 |
| 22037378 | 10.1038/nbt.1990 | Epidermal growth factor receptor | 12 |
| 22037378 | 10.1038/nbt.1990 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | 10 |
| 26254279 | 10.18632/oncotarget.4214 | Dual specificity mitogen-activated protein kinase kinase 1 | 9 |
| - | 10.6019/CHEMBL4689842 | U2OS | 9 |
| - | 10.6019/CHEMBL5724696 | U2OS | 8 |
| 22037378 | 10.1038/nbt.1990 | Mast/stem cell growth factor receptor Kit | 8 |
| 27448918 | 10.1016/j.ejmech.2016.06.043 | Molecular identity unknown | 7 |
| 22037378 | 10.1038/nbt.1990 | Receptor-type tyrosine-protein kinase FLT3 | 7 |
| - | 10.6019/CHEMBL5608141 | Colon cancer organoid | 6 |
| - | 10.1158/2159-8290.CD-23-0050 | Colon cancer organoid | 5 |
| 29191878 | 10.1126/science.aan4368 | Unchecked | 5 |
| - | 10.6019/CHEMBL4689842 | HEK-293T | 5 |
| 22037378 | 10.1038/nbt.1990 | Proto-oncogene tyrosine-protein kinase receptor Ret | 4 |
| 26611920 | 10.1016/j.bmcl.2015.11.004 | Rattus norvegicus | 4 |
| 23474388 | 10.1016/j.bmcl.2013.02.028 | Rattus norvegicus | 4 |
| 27448918 | 10.1016/j.ejmech.2016.06.043 | HT-29 | 3 |
Data from ChEMBL 36 via Core Engine